Difference between Thrombolytic Agent and Thrombolytic

THROMBOLYTIC AGENT vs THROMBOLYTIC: NOUN

A kind of pharmaceutical that can break up clots blocking the flow of blood to the heart muscle

A kind of pharmaceutical that can break up clots blocking the flow of blood to the heart muscle

Calcitonin, Nebulization, Primidone, Secondary amenorrhea, Angina pectoris, Activase, Apomorphine, Flecainide, Duros, Tambocor, Nadolol, Dihydroergotamine, Dihydrochloride, Clot buster, Thrombolytic

Antineoplastic, Endarterectomy, Beta blocker, Embolic, Stenting, Vasodilator, Angina pectoris, Angioplasty, Antiarrhythmic, Thrombectomy, Fibrinolysis, Streptokinase, Thrombolysis, Clot buster, Thrombolytic agent

Sulindac, Busulfan, Calcitonin, Nebulization, Primidone, Secondary amenorrhea, Angina pectoris, Apomorphine, Flecainide, Duros, Tambocor, Nadolol, Dihydroergotamine, Dihydrochloride, Thrombolytic

Percutaneous, Embolus, Antineoplastic, Endarterectomy, Beta blocker, Embolic, Vasodilator, Angina pectoris, Angioplasty, Antiarrhythmic, Thrombectomy, Fibrinolysis, Streptokinase, Thrombolysis, Thrombolytic agent

The results indicate that our chemically induced model is useful for screening and evaluating a thrombolytic agent.
Occasionally a prolonged infusion of a thrombolytic agent is required.
Alteplase is a commonly used thrombolytic agent in hospital settings.
Intravenous urokinase was the most effective thrombolytic agent.

Alteplase is a commonly used thrombolytic agent in hospital settings.
Introduction of other thrombolytic into central artery, percutaneous approach.
Introduction of other thrombolytic into peripheral artery, open approach.
Introduction of other thrombolytic into central artery, open approach.
Anticoagulant and thrombolytic medications need to be handled carefully.
Thrombolytic therapy with Streptokinase in acute ischemic stroke.
This paper reviews thrombolytic treatment for catheter obstruction.
Intravenous urokinase was the most effective thrombolytic agent.
Thrombolytic therapy of acute ischemic stroke during pregnancy.
The exclusion of women from clinical trials of thrombolytic therapy: implications for developing the thrombolytic predictive instrument database.

What are the contraindications to thrombolytic therapy for deep vein thrombosis (DVT)?
What is the value of PCI for patients who are not thrombolytic?
Which thrombolytic agents are used in the treatment of pulmonary embolism (PE)?
When should thrombolytic therapy be considered in patients with hemodynamically unstable PE?
When is thrombolytic therapy indicated in the treatment of myocardial infarction?
What are the possible complications of thrombolytic therapy for rtPA?
Is thrombolytic therapy effective for pediatric CSVT in children?
When should thrombolytic therapy be used in infective endocarditis?
When was streptokinase first used as a thrombolytic agent?
How are thrombolytic drugs given to treat blood clots?